This week we’re diving into healthcare; what could be more critical? To help me understand how behavioural science is impacting this field, I’m joined by Dr. Ada Le, healthcare expert at BEworks and Dr. Mousumi Sannigrahi, newly installed as Head of Commercial for Innovative Medicines at Fosun Pharma US, having spent the last 8 years at Novartis Pharma.Show notesWhat’s happening at the intersection of behavioural science and the pharma industry?How behavioural science plays out at Fosun vs. NovartisThe next frontier for healthcare and behavioural scienceWhat needs to happen to move to a more human-centric approach to healthcare?The goal of the 1% Steps for Health Care Reform ProjectWhat are easy wins that the pharma industry can enact now?Psychological barriers for patients with autoimmune disease Rosy retrospection bias and failure to prescribe the right treatmentDavid Robson and expectation effects: how mindset can alter our livesDan Ariely’s end of life theories and researchThe scientific method of problem solving vs. more subtle placebo effectsHopes for healthcare in the next year Hosted on Acast. See acast.com/privacy for more information.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related